Udenafil CAS 268203-93-6

Udenafil is the fourth in a class of drugs targeting the inhibition of the enzyme phosphodiesterase 5 (PDE5) for the treatment of erectile dysfunction. Inhibition of PDE5 results in the increase in endogenous cyclic guanosine monophosphate (cGMP) concentrations in the penile corpus cavernosum. cGMP induces smooth muscle cell relaxation and subsequent increased blood flow leading to a sustainable erection. Udenafil is a potent antagonist of human PDE5 with an IC₅₀ of 8.25nM and a comparable selectivity profile as sildenafil for the other PDEs. Unlike tadalafil, it does not inhibit PDE11, which has been implicated in myalgia and testicular toxicity. Furthermore, udenafil produced up to a 91% vaginal penetration success rate and up to a 67% intercourse completion rate compared to a 29% completion rate by placebo. Overall patient satisfaction, measured by a standard global assessment question, was 86% compared to only 26% in the placebo group. The most frequently recorded adverse events were mild-to-moderate facial flushing and headache.

Udenafil is an inhibitor of phosphodiesterase 5 (PDE5). In vivo, udenafil (1 and 5 mg/kg) increases lung cGMP levels, attenuates the development of compensatory right ventricular hypertrophy, and reduces pulmonary arterial wall thickening in a rat model of monocrotaline-induced pulmonary hypertension. It increases creatine clearance and decreases blood urea nitrogen (BUN) and serum malondialdehyde (MDA) levels in a rat model of renal ischemia-reperfusion injury. Udenafil (0.3 and 10 mg/kg) induces penile erections in conscious rabbits and in rabbits with acute spinal cord injury.

Çuňňur hyzmatdaşlygy bolan ýokary hilli önümler we bäsdeşlik bahalary bilen üpjün edip biljek köp sanly ýokary hilli zawodlarymyz bar. Şeýle hem, köpçülikleýin satyn almak üçin arzanladyş berip bileris. Köp hünärli ýük ekspeditor kompaniýalary bilen hyzmatdaşlyk edýäris, önümleri ygtybarly we rahat eliňize berip bileris. Eltip beriş wagty, töleg tassyklanandan 3-20 gün soň.

Product Name:	Udenafil
Synonyms:	5-[2-propyloxy-5-(2-(1-Methylpyrrolidin-2-yl)ethylaMinosulphonyl)phenyl]-1-Methyl-3-propyl-6,7-dihydro-1H-pyrazolo(4,3-d)pyriMidin-7-one;5-[2-propyloxy-5-[2-(1-Methyl-2-pyrrolidinyl)ethylaMinosulfonyl]phenyl]-1-Methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyriMidine-7-one;Zydena;Udenafil(DA 8159,Zydena);BenzenesulfonaMide,3-(6,7-dihydro-1-Methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyriMidin-5-yl)-N-[2-(1-Methyl-2-pyrrolidinyl)ethyl]-4-propoxy-;Udenafil, DA 8159;CS-1353;Udenafil, >=98%
CAS:	268203-93-6
MF:	C25H36N6O4S
MW:	516.66
EINECS:	251-228-4
Product Categories:	Intermediates & Fine Chemicals;Pharmaceuticals
Mol File:	268203-93-6.mol

1. Siz zawodmy ýa-da söwda kompaniýasymy?
Biz bir bitewi hyzmaty hödürleýän senagaty we söwdany birleşdirýän birleşdiriji. OEM kabul edilip bilner.

2. Nusga berýärsiňizmi? Mugtmy ýa-da goşmaça?
Mugt nusgalar. Nusganyň ýük tölegini siziň tarapyňyz tölemeli.

3. Hil gözegçiligi bilen baglanyşykly şahadatnamalaryňyz barmy?
Hilini üpjün etmek üçin ISO 9001: 2008 kepilnamasy.

4. Sitata almak üçin näme bermeli?
Size zerur önümiň görnüşi, sargyt mukdary, salgysy we aýratyn talaplary barada habar beriň. Sitata salgylanma üçin wagtynda berler.

5. Haýsy töleg usulyny has gowy görýärsiňiz? Haýsy şertler kabul edilýär?
Kabul edilen gowşuryş şertleri: FOB, CFR, CIF, EXW;
Kabul edilen töleg walýutasy: USD;
Kabul edilen töleg görnüşi: T / T, Western Union; Paypal, Söwda kepilligi.
Gepleşik dili: Iňlis.